ストックスクリーナーアプリを入手
10.45
0.29%
-0.03
アフターアワーズ：
10.45
前日終値:
$10.48
開ける：
$10.42
24時間の取引高:
6.18M
Relative Volume:
0.66
時価総額：
$12.18B
収益：
$14.33B
当期純損益:
$-3.79B
株価収益率:
-3.2965
EPS:
-3.17
ネットキャッシュフロー:
$1.84B
1週間 パフォーマンス:
-1.04%
1か月 パフォーマンス:
+7.73%
6か月 パフォーマンス:
+8.29%
1年 パフォーマンス:
-6.11%
1日の値動き範囲:
$10.37
$10.55
1週間の範囲:
$10.29
$10.61
52週間の値動き範囲:
$6.85
$13.55
Viatris Inc Stock (VTRS) Company Profile
VTRS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
10.45 | 12.22B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
149.79 | 67.25B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.27 | 48.23B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.75 | 43.59B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.68 | 22.14B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
403.80 | 17.85B | 2.99B | 1.21B | 1.13B | 25.06 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-06 | 開始されました | Goldman | Neutral |
| 2024-07-19 | 再開されました | Jefferies | Buy |
| 2023-10-23 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-06-23 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2023-04-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2023-02-17 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-27 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-10 | アップグレード | UBS | Sell → Neutral |
| 2022-11-08 | アップグレード | Piper Sandler | Underweight → Neutral |
| 2022-10-21 | 再開されました | Jefferies | Hold |
| 2022-06-14 | 開始されました | UBS | Sell |
| 2022-05-10 | ダウングレード | Piper Sandler | Neutral → Underweight |
| 2022-03-01 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-01 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-06-15 | 開始されました | Citigroup | Neutral |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2021-03-08 | ダウングレード | Goldman | Buy → Neutral |
| 2021-03-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-02-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2021-01-05 | 開始されました | Argus | Hold |
| 2020-12-14 | 開始されました | Bernstein | Mkt Perform |
すべてを表示
Viatris Inc (VTRS) 最新ニュース
Is Viatris Inc. Starting a New UptrendEarnings Summary Report & Reliable Momentum Entry Alerts - beatles.ru
Viatris Inc. Forms Double Bottom Pattern — Eyes on Breakout2025 Market WrapUp & Fast Moving Market Watchlists - beatles.ru
What makes Viatris Inc. stock attractive to long term investorsQuarterly Trade Report & AI Forecasted Stock Moves - beatles.ru
Is Viatris Inc. reversing from oversold territoryPortfolio Performance Summary & Consistent Growth Equity Picks - Newser
Custom strategy builders for tracking Viatris Inc.July 2025 Summary & Free Long-Term Investment Growth Plans - Newser
Stock Analysis | Viatris OutlookA Technical Bear Market with Mixed Fundamentals - AInvest
Candlestick signals on Viatris Inc. stock todayJuly 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - Newser
How volatile is Viatris Inc. stockJuly 2025 Action & Free High Accuracy Swing Entry Alerts - خودرو بانک
Will a bounce in Viatris Inc. offer an exitJuly 2025 Short Interest & Weekly Top Performers Watchlists - Newser
When is the best time to exit Viatris Inc.Weekly Stock Analysis & Verified Chart Pattern Signals - Newser
Generic Drugs Market is expected to reach US$ 942.69 billion - openPR.com
How to escape a deep drawdown in Viatris Inc.Earnings Risk Summary & Smart Swing Trading Alerts - Newser
What high frequency data says about Viatris Inc.2025 Institutional Moves & Detailed Earnings Play Strategies - Newser
How to use a screener to detect Viatris Inc. breakoutsVolume Spike & Expert Curated Trade Setups - Newser
Fda discontinues manufacture of Dymista, nasal spray, 137 ug 50 ug - MarketScreener
Trend analysis for Viatris Inc. this week2025 Price Targets & Safe Entry Point Identification - Newser
How to use Fibonacci retracement on Viatris Inc.2025 Earnings Surprises & Weekly Return Optimization Alerts - Newser
Zacks Investment Ideas feature highlights: Church & Dwight, Eli Lilly and Viatris - sharewise.com
Using economic indicators to assess Viatris Inc. potential2025 Risk Factors & Expert Curated Trade Setups - Newser
Risk adjusted return profile for Viatris Inc. analyzedGold Moves & Verified Momentum Stock Alerts - Newser
How moving averages guide Viatris Inc. trading2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Using fundamentals and technicals on Viatris Inc.Earnings Recap Report & Expert Approved Momentum Trade Ideas - Newser
Evaluating Viatris Inc. with trendline analysisEarnings Performance Report & Safe Capital Growth Trade Ideas - Newser
Statistical indicators supporting Viatris Inc.’s strengthStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
Can machine learning forecast Viatris Inc. recovery2025 Top Decliners & Fast Gain Swing Trade Alerts - Newser
Using data tools to time your Viatris Inc. exitJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser
Can Viatris Inc. recover in the next quarterCPI Data & Expert Approved Momentum Ideas - Newser
Is Viatris Inc. a cyclical or defensive stockJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - خودرو بانک
What are the risks of holding Viatris Inc.Weekly Risk Summary & Low Volatility Stock Suggestions - خودرو بانک
Is Viatris Inc. stock a top performer YTDQuarterly Risk Review & Fast Exit and Entry Trade Guides - خودرو بانک
Can Viatris Inc. deliver consistent EPS growthJuly 2025 Review & Stepwise Trade Signal Guides - خودرو بانک
Can Viatris Inc. navigate macro headwindsQuarterly Investment Review & Free Daily Entry Point Trade Alerts - خودرو بانک
Analyzing recovery setups for Viatris Inc. investorsMarket Performance Report & Advanced Technical Signal Analysis - Newser
Epinephrine Market to Size to Reach USD 5.74 Billion by 2032 as Demand for Emergency Allergy Treatments Surges – SNS Insider - GlobeNewswire Inc.
Did Viatris’ (VTRS) Executive Reshuffle Centralize Transformation or Signal a Deeper Strategic Shift? - simplywall.st
Real time pattern detection on Viatris Inc. stockWeekly Trend Recap & Comprehensive Market Scan Insights - Newser
Advanced analytics toolkit walkthrough for Viatris Inc.Forecast Cut & Low Drawdown Momentum Trade Ideas - Newser
Combining machine learning predictions for Viatris Inc.Quarterly Trade Review & High Accuracy Trade Alerts - Newser
Why Viatris Inc. stock attracts strong analyst attentionMarket Weekly Review & Low Risk Growth Stock Ideas - Newser
What to expect from Viatris Inc. in the next 30 days2025 Sector Review & Risk Adjusted Buy and Sell Alerts - Newser
Should you hold or exit Viatris Inc. nowIPO Watch & Fast Moving Market Watchlists - Newser
Applying Wyckoff theory to Viatris Inc. stockBond Market & Real-Time Stock Movement Alerts - Newser
Viatris Inc (VTRS) 財務データ
収益
当期純利益
現金流量
EPS
Viatris Inc (VTRS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Smith Scott Andrew | Chief Executive Officer |
May 12 '25 |
Buy |
8.94 |
60,000 |
536,262 |
292,807 |
| Le Goff Corinne | Chief Commercial Officer |
Apr 15 '25 |
Option Exercise |
0.00 |
41,112 |
0 |
60,441 |
| FINNEY ELISHA W | Director |
Mar 04 '25 |
Option Exercise |
0.00 |
18,977 |
0 |
37,832 |
| Le Goff Corinne | Chief Commercial Officer |
Mar 04 '25 |
Option Exercise |
0.00 |
37,894 |
0 |
36,721 |
| Campbell Paul | See Remarks |
Mar 04 '25 |
Option Exercise |
0.00 |
207,325 |
0 |
328,250 |
| Campbell Paul | See Remarks |
Mar 03 '25 |
Option Exercise |
0.00 |
19,348 |
0 |
144,590 |
| Vivaldi Coelho Rogerio | Director |
Mar 04 '25 |
Option Exercise |
0.00 |
21,691 |
0 |
21,691 |
| Smith Scott Andrew | Chief Executive Officer |
Mar 04 '25 |
Option Exercise |
0.00 |
96,431 |
0 |
266,825 |
| Smith Scott Andrew | Chief Executive Officer |
Mar 03 '25 |
Option Exercise |
0.00 |
146,700 |
0 |
221,178 |
| PARRISH MARK W | Director |
Mar 04 '25 |
Option Exercise |
0.00 |
18,977 |
0 |
140,395 |
2.24%
1.52%
大文字化:
|
ボリューム (24 時間):